Clinical

This channel newsfeed includes clinical content on treating patients or the clinical implications in a variety of cardiac subspecialties and disease states. The channel includes news on cardiac surgery, interventional cardiology, heart failure, electrophysiology, hypertension, structural heart disease, use of pharmaceuticals, and COVID-19.   

RSS icon

Genetic mutation linked to rare heart disease

Researchers at the University of Colorado Anschutz Medical campus have discovered a link between a genetic mutation and left ventricular noncompaction.

AHA 2016: Treatment strategy with rivaroxaban may decrease bleeding in patients undergoing PCI, requiring stenting

Patients with nonvalvular atrial fibrillation who underwent PCI with stenting had a lower rate of clinically significant bleeding if they received treatment regimen that included rivaroxaban than if they received a standard regimen that included a vitamin K antagonist, according to a randomized trial.

FDA approves Medtronic’s CRT device for heart failure patients

The FDA approved the Claria MRI quad cardiac resynchronization therapy (CRT) defibrillator for patients with heart failure.

New study supports need for cardiac rehab programs

Automatic enrollment post-surgery could save 25,000 lives and prevent 180,000 hospitalizations annually. 

Swollen joints, anti-inflammatories are hard on the heart

The anti-inflammatory drugs used by osteoarthritis and rheumatoid arthritis patients could be increasing risks of cardiovascular disease (CVD).

New Post-Hoc Analysis Supports YOSPRALA™ Efficacy And Safety In Previous Heart Attack Patients Who Need Daily Aspirin Therapy To Prevent A Second Cardiovascular Event

MISSISSAUGA, Ontario, Nov. 14, 2016 /PRNewswire/ --Aralez Pharmaceuticals Inc. (NASDAQ: ARLZ) (TSX: ARZ) ("Aralez" or the "Company") today announced new data for YOSPRALA™, a recently FDA-approved prescription fixed-dose combination of aspirin, an anti-platelet agent, and omeprazole, a proton pump inhibitor (PPI), demonstrated significantly lower rates of gastric and duodenal ulcers compared to aspirin alone among patients with a history of myocardial infarction at risk for secondary cardiovascular events and gastrointestinal problems related to aspirin therapy at the annual American Heart Association Scientific Sessions.

Cardiovascular biomarker score helps identify atrial fibrillation patients at risk of stroke, death

An analysis of a randomized trial found that a cardiovascular biomarker score may help predict the risk for stroke, systemic embolic events and death in patients with atrial fibrillation.

New app aims to protect veterans' hearts

Technology allows veterans to track their diet and exercise regimes to protect their hearts. 

Displaying 6161 - 6168 of 10758

Around the web

Radiology Business
Key takeaways from RSNA 2024 for AI, CT, MRI and the radiology staffing shortage

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Health Imaging
Use of AI opportunistic screening in CT for cardiovascular disease

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.